Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05192876

Analysis of Outcomes and Adverse Events of Patients Undergoing Radiation Therapy

Analysis of outcomes and adverse events of patients undergoing radiation therapy. Quality control using data base of patient records 2000-2025

Recruiting

Interested in participating?

Request Info

Key information

Age range

16 year–105 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Kantonsspital Winterthur

Winterthur, Canton of Zurich, 8401, Switzerland

Location status: Recruiting

Location contact

Daniel R Zwahlen, MD, MBA

CONTACT

[email protected]

+4152662645

About this study

What are the findings of the systematic recording and analysis of the outcomes and adverse events of radiotherapy, and how do these findings improve radiotherapy for future patients?

The goals of the systematic collection and analysis of patient-related personal data include:

  • Quality assurance and showing where the quality can be improved
  • Recording the outcomes and side effect profile of radiotherapy and adapting to prevent serious side effects in the future
  • Presentation and publication as part of the clinical research program at the Institute for Radio-Oncology of the Winterthur Cantonal Hospital

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients who are being treated with radiotherapy at the Department of Radiation Oncology at the Winterthur Cantonal Hospital

Exclusion criteria

  • No radiotherapy at the Department of Radiation Oncology at the Winterthur Cantonal Hospital <16 years,> 105 years

Treatment and study plan

Radiotherapy

Radiation

Outcomes and adverse events using radiation therapy

Primary outcomes

  1. Overall survival (OS) and progression free survival (PFS) analysis after radiation therapy

    Time frame: 25 years

    Calculation of Overall survival (OS) and progression free survival (PFS). Time-to-event endpoints are summarized as the median and corresponding 95% confidence interval using Kaplan-Meier method

  2. Analysis of risk factors influencing outcome after radiation therapy

    Time frame: 25 years

    Calculation of log-rank tests. If possible, hazard ratios are calculated via Cox regression. Competing risk analysis is conducted as supportive analysis

Secondary outcomes

  1. Number of patients with acute and late adverse events after radiation therapy

    Time frame: 25 years

    Predefined toxicity events are described by type, grade, frequency, and percentage across all time points. Fisher's exact tests are used for comparison (base line and defined time points). Quality of life symptom and function scales are used. Two-tailed tests with a significance level of 0.05 are used for all analyses. Adjustments for multiple testing may be used. Some of the analyses are exploratory and hypothesis generating

Study contacts

Contact information is provided by the study sponsor or research team.

Daniel R Zwahlen, MD, MBA

CONTACT

[email protected]

+41522662645

Romy Frey

CONTACT

[email protected]

+41522662645

Sponsors and collaborators

Lead sponsor

Daniel Zwahlen

Other

Registry information

Official study title

Analysis of Outcomes and Adverse Events of Patients Undergoing Radiation Therapy. Quality Control Using Data Base of Patient Records 2000-2025

Important dates

Study start
2000
Primary completion
2025
Study completion
2025
First posted
Jan 14, 2022
Registry last updated
May 21, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.